{"title":"不同类型肺癌与神经退行性疾病之间的关系:一项双样本孟德尔随机化研究","authors":"Wentao Zheng, Ying Wang, Enjiang Zhu, Rui Xu, Ling Zhu","doi":"10.1097/MD.0000000000045048","DOIUrl":null,"url":null,"abstract":"<p><p>Previous observational studies demonstrated that lung cancer and both Alzheimer disease (AD) and Parkinson disease (PD) may be related. However, the results of different studies are still controversial, possibly due to differences in the types of lung cancer examined. To date, no research has discussed it further yet. In this study, Mendelian randomization (MR) analysis was employed to investigate the relationship between different types of lung cancer and neurodegenerative diseases. We extracted data sets related to the exposure (lung cancer) and outcomes (AD/PD) from the Integrative Epidemiology Unit open Genome-Wide Association Study project. Then, we carried out two-sample MR analyses to explore the connection between lung cancer and both AD and PD. We also conducted sensitivity analyses on positive results from the MR analysis to make sure the results were accurate. Our two-sample MR analyses revealed that lung squamous cell carcinoma (LUSC) is negatively related to AD (OR = 0.935, 95% CI [0.892-0.980], P = .005). According to the sensitivity and heterogeneity analyses, no heterogeneity (P = .223) and pleiotropy (P = .548) were observed in this positive result. Thus, the findings were reliable. The IVW findings suggested that LUSC and PD did not significantly correlate (OR = 0.920, 95% CI [0.778-1.089], P = .332). Similarly, there was no obvious connection between lung adenocarcinoma and AD (OR = 0.968, 95% CI [0.915-1.025], P = .270) and PD (OR = 0.981, 95% CI [0.851-1.130], P = .787), according to IVW results. Results of two-sample MR analyses revealed that LUSC and a decreased risk of AD may be related.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":"104 40","pages":"e45048"},"PeriodicalIF":1.4000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12499675/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study.\",\"authors\":\"Wentao Zheng, Ying Wang, Enjiang Zhu, Rui Xu, Ling Zhu\",\"doi\":\"10.1097/MD.0000000000045048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Previous observational studies demonstrated that lung cancer and both Alzheimer disease (AD) and Parkinson disease (PD) may be related. However, the results of different studies are still controversial, possibly due to differences in the types of lung cancer examined. To date, no research has discussed it further yet. In this study, Mendelian randomization (MR) analysis was employed to investigate the relationship between different types of lung cancer and neurodegenerative diseases. We extracted data sets related to the exposure (lung cancer) and outcomes (AD/PD) from the Integrative Epidemiology Unit open Genome-Wide Association Study project. Then, we carried out two-sample MR analyses to explore the connection between lung cancer and both AD and PD. We also conducted sensitivity analyses on positive results from the MR analysis to make sure the results were accurate. Our two-sample MR analyses revealed that lung squamous cell carcinoma (LUSC) is negatively related to AD (OR = 0.935, 95% CI [0.892-0.980], P = .005). According to the sensitivity and heterogeneity analyses, no heterogeneity (P = .223) and pleiotropy (P = .548) were observed in this positive result. Thus, the findings were reliable. The IVW findings suggested that LUSC and PD did not significantly correlate (OR = 0.920, 95% CI [0.778-1.089], P = .332). Similarly, there was no obvious connection between lung adenocarcinoma and AD (OR = 0.968, 95% CI [0.915-1.025], P = .270) and PD (OR = 0.981, 95% CI [0.851-1.130], P = .787), according to IVW results. Results of two-sample MR analyses revealed that LUSC and a decreased risk of AD may be related.</p>\",\"PeriodicalId\":18549,\"journal\":{\"name\":\"Medicine\",\"volume\":\"104 40\",\"pages\":\"e45048\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12499675/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MD.0000000000045048\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000045048","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
以往的观察性研究表明,肺癌可能与阿尔茨海默病(AD)和帕金森病(PD)有关。然而,不同研究的结果仍然存在争议,这可能是由于所检查的肺癌类型的差异。到目前为止,还没有研究进一步讨论它。本研究采用孟德尔随机化(Mendelian randomization, MR)分析探讨不同类型肺癌与神经退行性疾病的关系。我们从综合流行病学单位开放全基因组关联研究项目中提取了与暴露(肺癌)和结果(AD/PD)相关的数据集。然后,我们进行了两样本MR分析,以探索肺癌与AD和PD之间的联系。我们还对MR分析的阳性结果进行了敏感性分析,以确保结果准确。我们的两样本MR分析显示,肺鳞状细胞癌(LUSC)与AD呈负相关(OR = 0.935, 95% CI [0.892-0.980], P = 0.005)。根据敏感性和异质性分析,该阳性结果不存在异质性(P = .223)和多效性(P = .548)。因此,研究结果是可靠的。IVW结果显示LUSC与PD无显著相关(OR = 0.920, 95% CI [0.778-1.089], P = 0.332)。肺腺癌与AD无明显相关性(OR = 0.968, 95% CI [0.915 ~ 1.025], P =。270)和PD (OR = 0.981, 95% CI [0.851 - -1.130], P =。根据IVW结果,787)。两样本MR分析结果显示LUSC和AD风险降低可能相关。
Association between different types of lung cancer and neurodegenerative diseases: A two-sample Mendelian randomization study.
Previous observational studies demonstrated that lung cancer and both Alzheimer disease (AD) and Parkinson disease (PD) may be related. However, the results of different studies are still controversial, possibly due to differences in the types of lung cancer examined. To date, no research has discussed it further yet. In this study, Mendelian randomization (MR) analysis was employed to investigate the relationship between different types of lung cancer and neurodegenerative diseases. We extracted data sets related to the exposure (lung cancer) and outcomes (AD/PD) from the Integrative Epidemiology Unit open Genome-Wide Association Study project. Then, we carried out two-sample MR analyses to explore the connection between lung cancer and both AD and PD. We also conducted sensitivity analyses on positive results from the MR analysis to make sure the results were accurate. Our two-sample MR analyses revealed that lung squamous cell carcinoma (LUSC) is negatively related to AD (OR = 0.935, 95% CI [0.892-0.980], P = .005). According to the sensitivity and heterogeneity analyses, no heterogeneity (P = .223) and pleiotropy (P = .548) were observed in this positive result. Thus, the findings were reliable. The IVW findings suggested that LUSC and PD did not significantly correlate (OR = 0.920, 95% CI [0.778-1.089], P = .332). Similarly, there was no obvious connection between lung adenocarcinoma and AD (OR = 0.968, 95% CI [0.915-1.025], P = .270) and PD (OR = 0.981, 95% CI [0.851-1.130], P = .787), according to IVW results. Results of two-sample MR analyses revealed that LUSC and a decreased risk of AD may be related.
期刊介绍:
Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.